Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Digestives & Intestinal Remedies market in Lebanon has been experiencing steady growth in recent years.
Customer preferences: Lebanese consumers are increasingly seeking digestive and intestinal remedies to alleviate common gastrointestinal issues. This can be attributed to changing dietary habits, stress levels, and a growing awareness of the importance of digestive health. Consumers in Lebanon are also becoming more health-conscious and are actively seeking natural and herbal remedies for their digestive problems.
Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Lebanon is the rising demand for probiotics and digestive enzymes. Probiotics are live bacteria and yeasts that are beneficial for digestion, while digestive enzymes help break down food and improve nutrient absorption. These products are gaining popularity among consumers as they offer a natural and effective solution for digestive issues. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive and intestinal remedies. Lebanese consumers are becoming more comfortable self-medicating and are opting for OTC products to treat their digestive problems. This trend is driven by convenience and cost-effectiveness, as OTC products are readily available in pharmacies and do not require a prescription.
Local special circumstances: Lebanon has a rich culinary tradition, and Lebanese cuisine is known for its diverse flavors and ingredients. However, the consumption of rich and spicy foods can often lead to digestive discomfort. As a result, there is a high demand for digestive and intestinal remedies in the country.
Underlying macroeconomic factors: Lebanon has a relatively high prevalence of gastrointestinal disorders, which is driving the demand for digestive and intestinal remedies. Factors such as stress, poor dietary habits, and sedentary lifestyles contribute to the prevalence of these disorders. Additionally, the growing awareness of the importance of digestive health and the availability of a wide range of products in the market are also contributing to the growth of the Digestives & Intestinal Remedies market in Lebanon. In conclusion, the Digestives & Intestinal Remedies market in Lebanon is experiencing growth due to changing customer preferences, including a preference for natural and herbal remedies, and the increasing availability of OTC products. The market is also driven by local special circumstances, such as the consumption of rich and spicy foods in Lebanese cuisine. Additionally, underlying macroeconomic factors, such as the high prevalence of gastrointestinal disorders and the growing awareness of digestive health, are contributing to the growth of the market.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights